SEC Form 4 · accession 0000885590-16-000084
Bausch Health Companies Inc. · BHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Howard Bradley Schiller
Director
Period of report
Jul 1, 2015
Accepted (ET)
Jan 4, 2016 · 6:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885590
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, no par valueF1,F2,F3 | Jul 1, 2015 | A | 1,506 | $0.00 | A | 590,875 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Prorated annual grant of restricted Share Units equal $343,750 divided by the closing price of registrant common stock on the date of grant.
- F2This number includes the maximum number of Common Shares that may be delivered in settlement of performance-based Restricted Share Units ("PSUs") that were previously reported on Form 4 in Table II. See note (3).
- F3The initial grant of PSUs was reported to vest based on total shareholder return ("TSR") between a price of $136.41 starting on December 1, 2014 and the average stock price for the 20 trading days starting on each measurement dates: 25% would vest on September 1, 2017, 50% on December 1, 2017 and 25% on March 1, 2018, (or 25% on September 1, 2018, 50% on December 1, 2018 and 25% on March 1, 2019, if applicable). Unit vesting is contingent on TSR performance between 10% and 30% into between one and three shares of common stock, respectively, with early vesting possible at higher TSR levels. These performance-based RSUs remain unvested for all 300,000 Common Shares.